Search
for
Sort by
Research 271–300 of 492
- Alopecia Areata and Vitamin D3 Deficiency: The Potential of Calcipotriol as a Treatment
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- 596 Application of an artificial intelligence (AI) photographic device to track platelet-rich plasma treatment outcomes in females with alopecia
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Comparative study of efficacy of excimer light therapy vs intralesional triamcinolone vs topical 5% minoxidil: an observational study
- Comparative study of efficacy of excimer light therapy vs. intralesional triamcinolone vs. topical 5% minoxidil for alopecia areata: an observational study
- Epidemiology and burden of alopecia areata: a systematic review
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Alopecia Areata
- Oxidative stress and alopecia areata
- Increase in IL-15 levels in patients with alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Unexpected Extensive Hair Whitening Following Baricitinib Treatment for Alopecia Universalis: A Case Report and Mechanistic Insights
- A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Alopecia Areata
- Practical Approach for Treatment lines of Alopecia Areata: Review Article
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata